Seeking Alpha

BMRN
  BioMarin Pharmaceutical Inc. - NASDAQ

11/1/2014, 7:40 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
BMRN vs. ETF Alternatives
Company Description
Biomarin Pharmaceutical Inc develops and commercializes pharmaceuticals for serious diseases and medical conditions. Its product portfolio is comprised of five product candidates Naglazyme, Kuvan, Aldurazyme, VIMIZIM and Firdapse.
Sector: Healthcare
Industry: Biotechnology
Country: United States